“Evaluation of Fondaparinux Use on Kidney Function in Hospitalized COVID-19 Patients with Decreased eGFR”, JFM, vol. 7, no. 2, pp. 359–370, Apr. 2025, doi: 10.35451/jfm.v7i2.2731.